These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10657739)

  • 41. Effects of leptin on insulin sensitivity in normal rats.
    Sivitz WI; Walsh SA; Morgan DA; Thomas MJ; Haynes WG
    Endocrinology; 1997 Aug; 138(8):3395-401. PubMed ID: 9231793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin delivery into the ventromedial nucleus of the hypothalamus affects differently feeding pattern and body weight in obese and lean Zucker rats.
    Fetissov SO; Meguid MM
    Appetite; 2010 Apr; 54(2):346-53. PubMed ID: 20060864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vagal hyperactivity due to ventromedial hypothalamic lesions increases adiponectin production and release.
    Suzuki Y; Shimizu H; Ishizuka N; Kubota N; Kubota T; Senoo A; Kageyama H; Osaka T; Hirako S; Kim HJ; Matsumoto A; Shioda S; Mori M; Kadowaki T; Inoue S
    Diabetes; 2014 May; 63(5):1637-48. PubMed ID: 24487025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasoactive agonists prevent erythrocyte extravasation in thrombocytopenic hamsters.
    Shepro D; Welles SL; Hechtman HB
    Thromb Res; 1984 Aug; 35(4):421-30. PubMed ID: 6484891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of norepinephrine release in the rat ventromedial hypothalamic nucleus in essential amino acid deficiency.
    Wang CX; Yang H; Perrott CJ; Gietzen DW
    Neurosci Lett; 1999 Jan; 259(1):53-5. PubMed ID: 10027554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic effects of chronic infusions of epinephrine and norepinephrine in rats.
    Racotta R; Ramirez-Altamirano L; Velasco-Delgado E
    Am J Physiol; 1986 May; 250(5 Pt 1):E518-22. PubMed ID: 3518485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tissue norepinephrine concentration in spontaneously diabetic Chinese hamsters.
    Feldman JM; Gerritsen GC
    Horm Res; 1988; 29(4):168-75. PubMed ID: 3065204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of serotonin on blood glucose and insulin levels of glucose- and streptozotocin-treated mice.
    Sugimoto Y; Kimura I; Yamada J; Watanabe Y; Takeuchi N; Horisaka K
    Jpn J Pharmacol; 1990 Sep; 54(1):93-6. PubMed ID: 2148781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic influences on glucose neurotoxicity, aging, and diabetes: a possible role for glucose hysteresis.
    Mobbs CV
    Genetica; 1993; 91(1-3):239-53. PubMed ID: 8125273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macronutrient-induced cascade of events leading to parallel changes in hypothalamic serotonin and insulin.
    Orosco M; Gerozissis K
    Neurosci Biobehav Rev; 2001 Mar; 25(2):167-74. PubMed ID: 11323081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperinsulinism in iron overload.
    Dandona P; Flynn DM; Hoffbrand AV
    Diabetologia; 1984 Dec; 27(6):610. PubMed ID: 6397388
    [No Abstract]   [Full Text] [Related]  

  • 52. Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
    Cincotta AH
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats.
    Luo S; Ezrokhi M; Cominos N; Tsai TH; Stoelzel CR; Trubitsyna Y; Cincotta AH
    Diabetol Metab Syndr; 2021 Jan; 13(1):11. PubMed ID: 33485386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circadian-timed dopamine agonist treatment reverses high-fat diet-induced diabetogenic shift in ventromedial hypothalamic glucose sensing.
    Stoelzel CR; Zhang Y; Cincotta AH
    Endocrinol Diabetes Metab; 2020 Jul; 3(3):e00139. PubMed ID: 32704560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.
    Moore MC; Smith MS; Swift LL; Cincotta AH; Ezrokhi M; Cominos N; Zhang Y; Farmer B; Cherrington AD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E133-E145. PubMed ID: 32459527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circadian peak dopaminergic activity response at the biological clock pacemaker (suprachiasmatic nucleus) area mediates the metabolic responsiveness to a high-fat diet.
    Luo S; Zhang Y; Ezrokhi M; Li Y; Tsai TH; Cincotta AH
    J Neuroendocrinol; 2018 Jan; 30(1):. PubMed ID: 29224246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sex differences in the effects of androgens acting in the central nervous system on metabolism.
    Morford J; Mauvais-Jarvis F
    Dialogues Clin Neurosci; 2016 Dec; 18(4):415-424. PubMed ID: 28179813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study.
    Roe ED; Chamarthi B; Raskin P
    J Diabetes Res; 2015; 2015():834903. PubMed ID: 26060825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus.
    Chamarthi B; Gaziano JM; Blonde L; Vinik A; Scranton RE; Ezrokhi M; Rutty D; Cincotta AH
    J Diabetes Res; 2015; 2015():157698. PubMed ID: 26060823
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.